David Requena

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

The Rockefeller University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

The Rockefeller University Jul 02 2016

United States

PHD :: Laboratory of Cellular Biophysics

Publications

Mahsa Shirani, Solomon N Levin, Bassem Shebl, David Requena, Tova M Finkelstein, Daniel S Johnson, Denise Ng, Gadi Lalazar, Søren Heissel, Peter Hojrup, Henrik Molina, Ype P de Jong, Charles M Rice, Aatur D Singhi, Michael S Torbenson, Philip Coffino, Barbara Lyons, Sanford M Simon
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Cancer research (2024)
Mahsa Shirani, Solomon N Levin, Bassem Shebl, David Requena, Tova M Finkelstein, Daniel S Johnson, Denise Ng, Gadi Lalazar, Søren Heissel, Peter Hojrup, Henrik Molina, Ype P de Jong, Charles M Rice, Aatur D Singhi, Michael S Torbenson, Philip Coffino, Barbara Lyons, Sanford M Simon
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Cancer research 84 (16) (2024)
David Requena, Rydberg R Supo-Escalante, Patricia Sheen, Mirko Zimic
Studying the dynamics of the drug processing of pyrazinamide in Mycobacterium tuberculosis. PloS one 19 (8) (2024)
David Requena, Rydberg R Supo-Escalante, Patricia Sheen, Mirko Zimic
Studying the dynamics of the drug processing of pyrazinamide in Mycobacterium tuberculosis. PloS one 19 (8) (2024)
Mahsa Shirani, Solomon N Levin, Bassem Shebl, David Requena, Tova M Finkelstein, Daniel S Johnson, Denise Ng, Gadi Lalazar, Søren Heissel, Peter Hojrup, Henrik Molina, Ype P de Jong, Charles M Rice, Aatur D Singhi, Michael S Torbenson, Philip Coffino, Barbara Lyons, Sanford M Simon
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Cancer research (2024)
Mahsa Shirani, Solomon N Levin, Bassem Shebl, David Requena, Tova M Finkelstein, Daniel S Johnson, Denise Ng, Gadi Lalazar, Søren Heissel, Peter Hojrup, Henrik Molina, Ype P de Jong, Charles M Rice, Aatur D Singhi, Michael S Torbenson, Philip Coffino, Barbara Lyons, Sanford M Simon
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Cancer research 84 (16) (2024)
Mahsa Shirani, Solomon N Levin, Bassem Shebl, David Requena, Tova M Finkelstein, Daniel S Johnson, Denise Ng, Gadi Lalazar, Søren Heissel, Peter Hojrup, Henrik Molina, Ype P de Jong, Charles M Rice, Aatur D Singhi, Michael S Torbenson, Philip Coffino, Barbara Lyons, Sanford M Simon
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Cancer research 84 (16) (2024)
Mahsa Shirani, Solomon N Levin, Bassem Shebl, David Requena, Tova M Finkelstein, Daniel S Johnson, Denise Ng, Gadi Lalazar, Søren Heissel, Peter Hojrup, Henrik Molina, Ype P de Jong, Charles M Rice, Aatur D Singhi, Michael S Torbenson, Philip Coffino, Barbara Lyons, Sanford M Simon
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Cancer research 84 (16) (2024)
Mahsa Shirani, Solomon N Levin, Bassem Shebl, David Requena, Tova M Finkelstein, Daniel S Johnson, Denise Ng, Gadi Lalazar, Søren Heissel, Peter Hojrup, Henrik Molina, Ype P de Jong, Charles M Rice, Aatur D Singhi, Michael S Torbenson, Philip Coffino, Barbara Lyons, Sanford M Simon
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Cancer research (2024)
Mahsa Shirani, Solomon N Levin, Bassem Shebl, David Requena, Tova M Finkelstein, Daniel S Johnson, Denise Ng, Gadi Lalazar, Søren Heissel, Peter Hojrup, Henrik Molina, Ype P de Jong, Charles M Rice, Aatur D Singhi, Michael S Torbenson, Philip Coffino, Barbara Lyons, Sanford M Simon
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Cancer research 84 (16) (2024)
Solomon N Levin, Michael D Tomasini, James Knox, Mahsa Shirani, Bassem Shebl, David Requena, Jackson Clark, Søren Heissel, Hanan Alwaseem, Rodrigo Cañada Trofo Surjan, Ron Lahasky, Henrik Molina, Michael S Torbenson, Barbara Lyons, Rachael D Migler, Philip Coffino, Sanford M Simon
Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma. Science advances 9 (25) (2023)
Gadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, Denise Ng, Patrick D Bhola, Ype P de Jong, Ruisi Wang, Nicole J C Narayan, Bassem Shebl, Solomon Levin, Eleftherios Michailidis, Mohammad Kabbani, Koen O A Vercauteren, Arlene M Hurley, Benjamin A Farber, William J Hammond, James A Saltsman, Ethan M Weinberg, J Fraser Glickman, Barbara A Lyons, Jessica Ellison, Erik Schadde, Martin Hertl, Jennifer L Leiting, Mark J Truty, Rory L Smoot, Faith Tierney, Tomoaki Kato, Hans-Guido Wendel, Michael P LaQuaglia, Charles M Rice, Anthony Letai, Philip Coffino, Michael S Torbenson, Michael V Ortiz, Sanford M Simon
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening. Cancer discovery 11 (10) (2021)
James A Saltsman, William J Hammond, Nicole J C Narayan, David Requena, Helmuth Gehart, Gadi Lalazar, Michael P LaQuaglia, Hans Clevers, Sanford Simon
A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing. Cancers 12 (9) (2020)
Dora Blitchtein, Karine Zevallos, M Reuven Samolski, David Requena, Chaska Velarde, Patricia Briceño, Marina Piazza, Michele L Ybarra
Feasibility and Acceptability of a Text Message-Based Smoking Cessation Program for Young Adults in Lima, Peru: Pilot Study. JMIR mHealth and uHealth 5 (8) (2017)
Diego Chowell, Luc G T Morris, Claud M Grigg, Jeffrey K Weber, Robert M Samstein, Vladimir Makarov, Fengshen Kuo, Sviatoslav M Kendall, David Requena, Nadeem Riaz, Benjamin Greenbaum, James Carroll, Edward Garon, David M Hyman, Ahmet Zehir, David B Solit, Michael F Berger, Ruhong Zhou, Naiyer A Rizvi, Timothy A Chan
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. Science (New York, N.Y.) 359 (6375) (2017)

David Requena.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Requena